FAKTOR-OPTIONSSCHEIN - INMODE Share Price

Certificat

DE000MD41HY3

Delayed Börse Stuttgart 16:59:57 28/06/2024 BST
0.3 EUR +11.11% Intraday chart for FAKTOR-OPTIONSSCHEIN - INMODE
Current month-18.18%
1 month-15.62%
Date Price Change
28/06/24 0.3 +11.11%
27/06/24 0.27 +3.85%
26/06/24 0.26 -7.14%
25/06/24 0.28 -6.67%
24/06/24 0.3 +7.14%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 04:59 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying INMODE LTD.
Issuer Morgan Stanley
WKN MD41HY
ISINDE000MD41HY3
Date issued 02/05/2022
Strike 12.04 $
Maturity Unlimited
Parity 19.59 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 19.99
Lowest since issue 0.25
Spread 0.01
Spread %3.33%

Company Profile

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Sector
-
More about the company

Ratings for InMode Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: InMode Ltd.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
18.06 USD
Average target price
25.6 USD
Spread / Average Target
+41.75%
Consensus